ovarian cancer chemotherapy

Over the decades, chemotherapy for ovarian cancer has evolved and currently involves a combination of intravenous platinum and taxane chemotherapy. Aug 18, 2016 - This page lists cancer drugs approved by the Food and Drug There may be drugs used in ovarian, fallopian tube, or primary peritoneal cancer that are not listed Chemotherapy and You: Support for People With Cancer. Mar 17, 2017 - Access a detailed treatment regimen chart for ovarian cancer, with a focus on primary chemotherapy/primary adjuvant therapy with IV and IP  Aug 4, 2015 - Confirming results of a landmark randomized trial, women with advanced ovarian cancer had significantly better survival when treated with  Currently, the standard treatment for stage III ovarian cancer consists of both surgery and chemotherapy. Unfortunately, less than 40% of patients experience  Hair loss is a common side effect of some, but not all, of the drugs used to treat ovarian cancer. In particular, carboplatin, the most widely used of them, rarely  Feb 9, 2017 - This topic review will cover chemotherapy treatment for ovarian cancer. Separate topic reviews are available that discuss the diagnosis and  May 28, 2010 - If you have ovarian cancer, you may feel overwhelmed by your diagnosis and treatment plan.


WebMD explains chemotherapy for ovarian  Jun 3, 2016 - ASCO Perspective. “Intraperitoneal (IP) chemotherapy is an effective yet underused treatment for women with newly diagnosed ovarian cancer  Dec 17, 2013 - Ovarian cancers are very sensitive to chemotherapy and often respond well initially. Unfortunately, in most cases, ovarian cancer recurs. To destroy any tumor cells that might remain after surgery for ovarian cancer, we often recommend that women receive chemotherapy or targeted therapy. We identified two cohorts of patients with stage III, optimally cytoreduced ovarian cancer (defined by GOG-172 criteria as ≤ 1 cm gross residual disease). Treatment for ovarian cancer usually involves a combination of surgery and chemotherapy. Less often, treatment may include radiotherapy. The type of treatment  Dec 22, 2016 - Intraperitoneal (IP) chemotherapy remains the preferred treatment for optimally debulked (<1 cm) stage III ovarian after front-line surgery  The primary treatments and therapies for ovarian cancer are surgery, chemotherapy and radiation therapy. In some cases, two or even all of these treatments  For most ovarian patients at CTCA, chemotherapy is an important part of treatment.


Chemotherapy uses drugs to destroy cancer cells and tumors in the  Chemotherapy is often an important form of treatment for ovarian cancer. The recommended regimen for a patient can vary based on several factors, including  Jan 24, 2017 - The best chemotherapy strategy (IP versus IV) for patients with ovarian cancer is still being debated. Franco M. Muggia, M.D., weighs in. Read about when, where and how you have chemotherapy for ovarian cancer, and the possible side effects. You may have chemotherapy on its own, or with surgery, to treat ovarian Jan 30, 2017 - Find out about the main treatments for ovarian cancer, including surgery and chemotherapy. Chemotherapy (chemo) uses anticancer medicines to kill cells. The medicines are made to attack and kill cancer cells that grow quickly. Learn more  Feb 4, 2016 - The standard approach is the combination of a platinum compound, such as cisplatin or carboplatin, and a taxane, such as paclitaxel (Taxol®) or docetaxel (Taxotere®). For IV chemotherapy, most doctors favor carboplatin over cisplatin because it has fewer side effects and is just as effective.


After surgery, chemo is recommended for at least 6 cycles. The combination of carboplatin and paclitaxel is most often used. Some women with stage II ovarian cancer are treated with intraperitoneal (IP) chemotherapy instead of intravenous (IV) chemotherapy. Ovarian epithelial fallopian tube cancer, and peritoneal cancer are usually specializes in gynecological cancers, including surgery and chemotherapy. LOS ANGELES (March 9, 2013)– Patients with advanced ovarian cancer who undergo intensive treatment with chemotherapy that bathes the abdomen are  The standard treatment for ovarian cancer consists of debulking surgery followed by six rounds of chemotherapy. One recent study found that just 37 percent of  Chemotherapy is a general term that is used to describe cancer-killing drugs. Many such drugs destroy cancer cells by preventing them from growing and  Feb 24, 2016 - The traditional treatment for ovarian cancer is surgery followed by rounds of monthly chemotherapy. The treatment is effective, but there is  Two large phase III trials in first-line ovarian have demonstrated a positive effect of bevacizumab when administered concurrently with chemotherapy and .

Immune Stimulant No Help When Added to Chemotherapy for Recurrent Ovarian Cancer - Targeted Oncology
Targeted OncologyImmune Stimulant No Help When Added to Chemotherapy for Recurrent Ovarian CancerTargeted OncologyAdding an immunotherapeutic agent to chemotherapy had no impact on survival in patients with recurrent, platinum-resistant ovarian cancer, according to a late-breaking trial reported at the 2017 Society of Gynecologic Oncology Annual Meeting held in 

Addressing the Link Between Neoadjuvant Chemo and Readmission Rates in Ovarian Cancer - Targeted Oncology
Targeted OncologyAddressing the Link Between Neoadjuvant Chemo and Readmission Rates in Ovarian CancerTargeted OncologyAdministering neoadjuvant chemotherapy to ovarian cancer patients who are likely to benefit from the treatment can not only result in decreased complication rates, but may also help comply with the push to decrease hospital readmission rates, says Emma L.and more »

FDA Approves Tesaro's PARP Inhibitor for Ovarian Cancer Maintenance Therapy - Genetic Engineering & Biotechnology News
TheStreet.comFDA Approves Tesaro's PARP Inhibitor for Ovarian Cancer Maintenance TherapyGenetic Engineering & Biotechnology NewsFDA approval of Zejula was based on data from the placebo-controlled Phase III ENGOT-OV16/NOVA study in 553 women with recurrent ovarian cancer who achieved either partial or complete remission on platinum-based chemotherapy. Maintenance FDA Approves Ovarian Cancer DrugSpecialty Pharmacy TimesTesaro Secures Early and Broad Approval for PARP Inhibitor in Ovarian CancerTheStreet.comTesaro's ovarian cancer drug wins early approvalThe Boston GlobeOncLive -Zacks.com -pharmaphorumall 90 news articles »

New Treatment Helping More Women Survive Ovarian Cancer - CBS Pittsburgh / KDKA
CBS Pittsburgh / KDKANew Treatment Helping More Women Survive Ovarian Cancer CBS Pittsburgh / KDKAPITTSBURGH (KDKA) – Every year, nearly 22,000 women are diagnosed with ovarian cancer and more than 14,000 die from it. Now, a relatively new treatment and more »

Maintenance Chemo After CR Fails to Extend Survival in Ovarian - Cancer Network
Maintenance Chemo After CR Fails to Extend Survival in Ovarian Cancer NetworkA long-term phase III trial found that maintenance chemotherapy did not improve overall survival over surveillance among women with advanced and more »

Maintenance Chemotherapy Yields No OS Benefit in Ovarian Cancer - OncLive
OncLiveMaintenance Chemotherapy Yields No OS Benefit in Ovarian CancerOncLiveMaintenance chemotherapy after debulking surgery and adjuvant platinum-based chemotherapy did not improve overall survival rates in women with ovarian and more »

Ovarian Cancer: Distinct Clusters of Chemotherapy Nonresponders - Oncology Nurse Advisor
Oncology Nurse AdvisorOvarian Cancer: Distinct Clusters of Chemotherapy Nonresponders Oncology Nurse AdvisorThree specific clusters of patients with serous epithelial ovarian cancer who do not respond to chemotherapy have been identified by researchers.and more »

Chemotherapy Fails To Prolong Survival in Low-grade Serous - Cancer Therapy Advisor
Cancer Therapy AdvisorChemotherapy Fails To Prolong Survival in Low-grade Serous Cancer Therapy AdvisorAdjuvant platinum-based chemotherapy did not improve survival in women with low-grade serous ovarian cancer.and more »

Your name (required)
Your e-mail (required)